Yona Geffen

Summary

Publications

  1. doi request reprint Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study
    Yona Geffen
    Avraham Pharmaceuticals, 42 Hayarkon St, Industrial Zone, Yavneh, 81227, Israel
    J Clin Psychiatry 73:e1168-74. 2012

Detail Information

Publications1

  1. doi request reprint Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study
    Yona Geffen
    Avraham Pharmaceuticals, 42 Hayarkon St, Industrial Zone, Yavneh, 81227, Israel
    J Clin Psychiatry 73:e1168-74. 2012
    ..On the basis of animal models, we tested the hypotheses that BL-1020 would be effective in ameliorating both psychotic symptoms and cognitive impairments, with a favorable safety profile in acutely ill schizophrenia patients...